The U.S. Food and Drug Administration (FDA) and drug manufacturer Novo Nordisk are warning consumers about “counterfeit” Ozempic found outside the authorized drug supply chain. The contents of the ...

"Many people with obesity suffer from co-morbidities," said Novo Nordisk's chief science officer Mads Krogsgaard Thomsen, in a statement. "Saxenda has the potential to help some of these people ...

The FDA and drugmaker Novo Nordisk on Monday warned that counterfeit ... In addition, fake products were found to include counterfeit needles, which means the FDA could not certify that the ...